Baxter International Aktie
| 18,47USD | -0,71USD | -3,70% |
WKN: 853815 / ISIN: US0718131099
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 50 000 | 60 000 | 60 000 | 60 000 | 38 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,23 | 0,21 | 0,25 | 0,25 | 0,28 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 8 411 | 8 872 | 8 011 | 9 600 | 8 853 |
| Summe Anlagevermögen | 11 608 | 24 649 | 20 276 | 18 676 | 16 929 |
| Summe Aktiva | 20 019 | 33 521 | 28 287 | 28 276 | 25 782 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 11 293 | 24 400 | 22 392 | 19 808 | 18 758 |
| Summe Eigenkapital | 8 726 | 9 121 | 5 895 | 8 468 | 7 024 |
| Summe Passiva | 20 019 | 33 521 | 28 287 | 28 276 | 25 782 |
Adresse
| One Baxter Parkway, 60015-4625 Deerfield | |
| Telefon | +1 (224) 948-2000 |
| Internet | http://www.baxter.com |
Management
|
Alok Sonig
Executive VP & President-Pharmaceuticals |
|
Amy A. McBride-Wendell
Independent Director |
|
Andrew P. Hider
President, Chief Executive Officer & Director |
|
Angela B. Lee
Chief Diversity Officer |
|
Anita A. Zielinski
Chief Accounting Officer, Senior VP & Controller |
|
Caitlin Kelly
Manager-Finance Team |
|
Catherine R. Smith
Independent Director |
|
Charles R. Patel
Chief Information Officer & Senior Vice President |
|
Clare Trachtman
Chief Investor Relations Officer & Senior VP |
|
D. Brent Shafer
Non-Executive Chairman |
|
David S. Rosenbloom
Executive Vice President & General Counsel |
|
David S. Wilkes
Independent Director |
|
Ellen K. Bradford
Secretary & Senior Vice President |
|
Gerard Greco
Chief Quality Officer & Senior Vice President |
|
Heather Wechet
VP-Talent Management & Employee Relations |
|
James W. Borzi
Chief Supply Chain Officer & Executive VP |
|
Jeanne K. Mason
Chief Human Resources Officer & Executive VP |
|
Jeffrey A. Craig
Independent Director |
|
Joel Todd Grade
Chief Financial Officer & Executive Vice President |
|
Karen L. Leets
Treasurer & Senior Vice President |
|
Lynn Pawelski
Vice President-Global Regulatory Affairs |
|
Nancy M. Schlichting
Lead Independent Director |
|
Nicolas Henry Roelofs
Development Manager |
|
Patricia B. Morrison
Independent Director |
|
Reaz Rasul
EVP, President-Healthcare Systems & Technologies |
|
Stacey T. Eisen
Chief Communications & Corporate Marketing Officer |
|
Stephen H. Rusckowski
Independent Director |
|
Stephen Newman Oesterle
Independent Director |
|
Tobi Karchmer
SVP, Chief Medical & Scientific Officer |
|
William A. Ampofo
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.